Chemours Historical Financial Ratios
| CC Stock | USD 26.73 0.30 1.14% |
Chemours is presently reporting on over 111 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0409 or PTB Ratio of 8.43 will help investors to properly organize and evaluate Chemours financial condition quickly.
Chemours |
About Chemours Financial Ratios Analysis
ChemoursFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Chemours investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Chemours financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Chemours history.
Chemours Financial Ratios Chart
Chemours Co financial ratios usually calculated using numerical values taken directly from Chemours financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about Chemours. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.
At present, Chemours' PTB Ratio is projected to increase slightly based on the last few years of reporting. The current year's Days Sales Outstanding is expected to grow to 49.08, whereas Price To Sales Ratio is forecasted to decline to 0.55. Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Chemours stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Chemours sales, a figure that is much harder to manipulate than other Chemours Co multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Chemours Co dividend as a percentage of Chemours stock price. Chemours dividend yield is a measure of Chemours stock productivity, which can be interpreted as interest rate earned on an Chemours investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.Most ratios from Chemours' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Chemours current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. At present, Chemours' PTB Ratio is projected to increase slightly based on the last few years of reporting. The current year's Days Sales Outstanding is expected to grow to 49.08, whereas Price To Sales Ratio is forecasted to decline to 0.55.
| 2020 | 2022 | 2023 (projected) | Dividend Yield | 0.0402 | 0.0324 | 0.0317 | Price To Sales Ratio | 0.82 | 0.7 | 0.78 |
Chemours fundamentals Correlations
Click cells to compare fundamentals
Chemours Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Chemours fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 0.75 | 0.54 | 0.82 | 0.87 | 0.7 | 0.78 | |
| Dividend Yield | 0.0296 | 0.055 | 0.0402 | 0.0324 | 0.0317 | 0.0409 | |
| Ptb Ratio | 4.33 | 5.02 | 5.12 | 4.3 | 6.37 | 8.43 | |
| Days Sales Outstanding | 44.52 | 37.54 | 41.42 | 33.63 | 36.94 | 49.08 | |
| Book Value Per Share | 4.18 | 4.94 | 6.55 | 7.13 | 4.95 | 8.76 | |
| Invested Capital | 6.39 | 5.26 | 3.63 | 3.44 | 5.49 | 9.2 | |
| Operating Cash Flow Per Share | 3.94 | 4.9 | 4.97 | 4.85 | 3.73 | 5.05 | |
| Stock Based Compensation To Revenue | 0.003438 | 0.00322 | 0.005359 | 0.003974 | 0.002987 | 0.003136 | |
| Capex To Depreciation | (1.55) | (0.83) | (0.87) | (1.05) | (1.21) | (1.27) | |
| Pb Ratio | 4.33 | 5.02 | 5.12 | 4.3 | 6.37 | 8.43 | |
| Free Cash Flow Per Share | 1.03 | 3.28 | 3.29 | 2.88 | 1.25 | 2.46 | |
| Roic | 0.0141 | 0.12 | 0.16 | 0.14 | (0.0136) | (0.0129) | |
| Inventory Turnover | 4.14 | 4.16 | 4.52 | 3.69 | 3.49 | 4.98 | |
| Net Income Per Share | (0.32) | 1.33 | 3.69 | 3.72 | (1.6) | (1.52) | |
| Days Of Inventory On Hand | 88.24 | 87.84 | 80.81 | 98.97 | 104.64 | 65.68 | |
| Payables Turnover | 4.84 | 4.76 | 4.27 | 4.14 | 4.16 | 5.16 | |
| Research And Ddevelopement To Revenue | 0.0124 | 0.0145 | 0.0187 | 0.0174 | 0.0179 | 0.019 | |
| Capex To Revenue | (0.087) | (0.0537) | (0.0437) | (0.0452) | (0.0614) | (0.0645) | |
| Cash Per Share | 5.72 | 6.71 | 8.8 | 7.09 | 12.13 | 12.74 | |
| Pocfratio | 4.38 | 4.59 | 5.06 | 6.31 | 8.45 | 4.9 | |
| Interest Coverage | 0.82 | 2.42 | 4.8 | 5.6 | (0.42) | (0.4) | |
| Payout Ratio | 0.15 | (3.15) | 0.75 | 0.27 | (0.63) | (0.59) | |
| Capex To Operating Cash Flow | (0.74) | (0.33) | (0.34) | (0.41) | (0.67) | (0.7) | |
| Pfcf Ratio | 17.64 | 7.56 | 10.19 | 10.64 | 25.25 | 26.51 | |
| Days Payables Outstanding | 75.49 | 76.7 | 85.44 | 88.18 | 87.77 | 63.0 | |
| Income Quality | (12.5) | 3.68 | 1.35 | 1.3 | (2.34) | (2.22) | |
| Roe | (0.0755) | 0.27 | 0.56 | 0.52 | (0.32) | (0.31) | |
| Ev To Operating Cash Flow | 9.91 | 8.99 | 9.77 | 9.9 | 12.93 | 8.53 | |
| Pe Ratio | (57.34) | 18.64 | 9.1 | 8.23 | (19.73) | (18.75) | |
| Return On Tangible Assets | (0.00734) | 0.0317 | 0.0817 | 0.0768 | (0.0292) | (0.0278) | |
| Ev To Free Cash Flow | 38.13 | 13.43 | 14.76 | 16.71 | 38.65 | 40.58 | |
| Earnings Yield | 0.2 | (0.0174) | 0.0536 | 0.12 | (0.0507) | (0.0481) | |
| Intangibles To Total Assets | 0.024 | 0.0236 | 0.0143 | 0.0151 | 0.0127 | 0.0121 | |
| Net Debt To E B I T D A | 7.18 | 3.83 | 2.06 | 2.25 | 11.33 | 11.89 | |
| Current Ratio | 1.93 | 1.8 | 1.83 | 1.7 | 1.54 | 1.33 | |
| Tangible Book Value Per Share | 3.16 | 3.93 | 5.91 | 6.39 | 4.26 | 7.71 | |
| Receivables Turnover | 8.2 | 9.72 | 8.81 | 10.85 | 9.88 | 6.7 |
Pair Trading with Chemours
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemours position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemours will appreciate offsetting losses from the drop in the long position's value.Moving against Chemours Stock
| 0.6 | DNMR | Danimer Scientific Financial Report 8th of May 2024 | PairCorr |
| 0.59 | ECL | Ecolab Inc Earnings Call This Week | PairCorr |
| 0.56 | CMT | Core Molding Technologies Financial Report 14th of May 2024 | PairCorr |
| 0.53 | ASH | Ashland Global Holdings Earnings Call This Week | PairCorr |
| 0.5 | CBT | Cabot Financial Report 13th of May 2024 | PairCorr |
The ability to find closely correlated positions to Chemours could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chemours when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chemours - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chemours Co to buy it.
The correlation of Chemours is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chemours moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chemours moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chemours can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Chemours information on this page should be used as a complementary analysis to other Chemours' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Chemours Stock analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |
Is Chemours' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.91) | Dividend Share 1 | Earnings Share (1.60) | Revenue Per Share 40.473 | Quarterly Revenue Growth 0.017 |
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.